Clinical Trial

An Effectiveness Trial Examining a Novel Approach to Cognitive Remediation in Individuals with PTSD

Study Description

An effectiveness trial for a short-term, CBT-based, cognitive remediation intervention called Goal Management Training (GMT). Participants will be individuals with a primary diagnosis of PTSD.

An effectiveness trial for a short-term, CBT-based, cognitive remediation intervention called Goal Management Training (GMT). Participants will be individuals with a primary diagnosis of PTSD (Post-traumatic Stress Disorder, as assessed by our team) who are also experiencing associated cognitive dysfunction (e.g., poor focus, memory, disorganization). After treatment, we expect to find a reduction in such cognitive dysfunction, as well as a reduction in PTSD symptom severity, and an increase in work readiness.

Location

Locations Selected Location

Methods

No pharmaceutical medication involved No pharmaceutical medication involved
Recruiting patients only Recruiting patients only

Questionnaire

All Self-administered Questionnaires, as well as consent, will be completed by participants via REDCap (Research Electronic Data Capture). Participants will be emailed web links to access the assessments the day they are to be completed.

GMT Treatment Session via Zoom

GMT is a CBT-based cognitive remediation program. Participants randomly assigned to the GMT group will be asked to attend nine weekly, 2-hour group sessions of GMT with 2 facilitators and 5-7 other participants.

Additional Information

Official Study Title

An Effectiveness Trial Examining a Novel Approach to Cognitive Remediation in Individuals with Post-Traumatic Stress Disorder (PTSD; including trauma related to COVID-19)

Clinical Trial ID

12916

ParticipAid ID

ejRGBe